| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5649771 | Journal of Investigative Dermatology | 2017 | 4 Pages |
Abstract
Data from the Spanish registry BIOBADADERM suggest that the risks of any infectious episode in patients treated with biologics are limited, not exceeding the risks observed with a conventional treatment such as cyclosporine. The registry lacked enough statistical power to analyze risks for severe infections. These should be the focus of further research, although the difficulties of “real-world” data analysis should not be trivialized.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Luigi Naldi,